Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

145 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase 2, open-label, randomized, multiple-dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis B.
Yuen MF, Chen CY, Liu CJ, Jeng WJ, Elkhashab M, Coffin CS, Kim W, Greenbloom S, Ramji A, Lim YS, Kim YJ, Fung SK, Kim DJ, Jang JW, Lee KS, Iyer RP, Macfarlane C, Jackson K, Locarnini SA, Chan HLY, Afdhal NH. Yuen MF, et al. Among authors: locarnini sa. Liver Int. 2023 Jan;43(1):77-89. doi: 10.1111/liv.15465. Epub 2022 Nov 11. Liver Int. 2023. PMID: 36300646 Clinical Trial.
Preface: Special Collection Commemorating John C. Martin.
Locarnini S, Richman D, Whitley R. Locarnini S, et al. Antivir Ther. 2022 Oct;27(5):13596535221123613. doi: 10.1177/13596535221123613. Antivir Ther. 2022. PMID: 36310438 Free article. No abstract available.
Hepatitis B Virus Flares After Nucleot(s)ide Analogue Cessation Are Associated With Activation of Toll-Like Receptor Signaling Pathways.
Hall SAL, Burns GS, Mooney BJ, Millen R, Morris R, Vogrin S, Sundararajan V, Ratnam D, Levy MT, Lubel JS, Nicoll AJ, Strasser SI, Sievert W, Desmond PV, Ngu MC, Angus P, Sinclair M, Meredith C, Matthews G, Revill PA, Jackson K, Littlejohn M, Bowden S, Locarnini SA, Thompson AJ, Visvanathan K. Hall SAL, et al. Among authors: locarnini sa. J Infect Dis. 2022 Dec 28;227(1):123-132. doi: 10.1093/infdis/jiac375. J Infect Dis. 2022. PMID: 36108079
Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels.
Hall SAL, Burns GS, Anagnostou D, Vogrin S, Sundararajan V, Ratnam D, Levy MT, Lubel JS, Nicoll AJ, Strasser SI, Sievert W, Desmond PV, Ngu MC, Angus P, Sinclair M, Meredith C, Matthews G, Revill PA, Jackson K, Littlejohn M, Bowden DS, Locarnini SA, Visvanathan K, Thompson AJ. Hall SAL, et al. Among authors: locarnini sa. Aliment Pharmacol Ther. 2022 Jul;56(2):310-320. doi: 10.1111/apt.16968. Epub 2022 May 6. Aliment Pharmacol Ther. 2022. PMID: 35521992
Origins and Evolution of the Primate Hepatitis B Virus.
Locarnini SA, Littlejohn M, Yuen LKW. Locarnini SA, et al. Front Microbiol. 2021 May 24;12:653684. doi: 10.3389/fmicb.2021.653684. eCollection 2021. Front Microbiol. 2021. PMID: 34108947 Free PMC article. Review.
Analysis of Hepatitis B Virus Haplotype Diversity Detects Striking Sequence Conservation Across Genotypes and Chronic Disease Phase.
Wagner J, Yuen L, Littlejohn M, Sozzi V, Jackson K, Suri V, Tan S, Feierbach B, Gaggar A, Marcellin P, Buti Ferret M, Janssen HLA, Gane E, Chan HLY, Colledge D, Rosenberg G, Bayliss J, Howden BP, Locarnini SA, Wong D, Thompson AT, Revill PA. Wagner J, et al. Among authors: locarnini sa. Hepatology. 2021 May;73(5):1652-1670. doi: 10.1002/hep.31516. Hepatology. 2021. PMID: 32780526
The evolution and clinical impact of hepatitis B virus genome diversity.
Revill PA, Tu T, Netter HJ, Yuen LKW, Locarnini SA, Littlejohn M. Revill PA, et al. Among authors: locarnini sa. Nat Rev Gastroenterol Hepatol. 2020 Oct;17(10):618-634. doi: 10.1038/s41575-020-0296-6. Epub 2020 May 28. Nat Rev Gastroenterol Hepatol. 2020. PMID: 32467580 Review.
145 results